CVEvulnerability
CVE-2018-14787
7.8 HIGH
Official page ↗
- Status
- Modified
- Published
- 2018-08-22
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.1 ([email protected])
- 7.8 HIGH — CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- CVSS 2.0 ([email protected])
- 4.6 MEDIUM — AV:L/AC:L/Au:N/C:P/I:P/A:P
- Weaknesses
- CWE-269
Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Affected configurations
• philips intellispace cardiovascular (<= 3.1)
• philips xcelera (<= 4.1)
Related
Weakness · CWE (1)
- CWE-269 Improper Privilege Management weakness
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 Third Party Advisory, US Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-security Vendor Advisory
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 Third Party Advisory, US Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-security Vendor Advisory